Show simple item record

dc.contributor.authorLi, Ryan
dc.contributor.authorRogier van Doorn, H
dc.contributor.authorWertheim, Heiman FL
dc.contributor.authorKhue, Luong N
dc.contributor.authorHa, Ngo TB
dc.contributor.authorDat, Vu Q
dc.contributor.authorHanh, Chu T
dc.contributor.authorNga, Do TT
dc.contributor.authorTrang, Nghiem NM
dc.contributor.authorBehzad, Nadjm
dc.contributor.authorCluzeau, Francoise
dc.contributor.authorKinh, Nguyen V
dc.contributor.authorTrung, Nguyen V
dc.contributor.authorHuong, Nguyen TL
dc.contributor.authorChau, Ngo Q
dc.contributor.authorHuong, La Q
dc.contributor.authorThao, Le T
dc.contributor.authorHong, Le TA
dc.contributor.authorOanh, Tran TM
dc.contributor.authorIslam, Jasmin
dc.contributor.authorRoberts, C Michael
dc.contributor.authorChalkidou, Kalipso
dc.date.accessioned2020-02-14T01:33:08Z
dc.date.available2020-02-14T01:33:08Z
dc.date.issued2016
dc.identifier.issn2214-109X
dc.identifier.doi10.1016/S2214-109X(16)30267-4
dc.identifier.urihttp://hdl.handle.net/10072/391456
dc.description.abstractAntimicrobial resistance is recognised as a serious global health threat requiring global action. However, much work remains to translate global strategies to combat antimicrobial resistance into national policy and action. In low-income and middle-income countries where vulnerable health-care systems require investment within constrained budgets, antimicrobial resistance strategies might not be prioritised, and indeed equitable versus restricted access to antibiotics present a conflicting challenge. 1
dc.languageEnglish
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofpagefromE789
dc.relation.ispartofpagetoE789
dc.relation.ispartofissue11
dc.relation.ispartofjournalLancet Global Health
dc.relation.ispartofvolume4
dc.subject.fieldofresearchMicrobiology
dc.subject.fieldofresearchcode3107
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsPublic, Environmental & Occupational Health
dc.titleCombating antimicrobial resistance: quality standards for prescribing for respiratory infections in Vietnam
dc.typeJournal article
dc.type.descriptionC3 - Articles (Letter/ Note)
dcterms.bibliographicCitationLi, R; Rogier van Doorn, H; Wertheim, HFL; Khue, LN; Ha, NTB; Dat, VQ; Hanh, CT; Nga, DTT; Trang, NNM; Behzad, N; Cluzeau, F; Kinh, NV; Trung, NV; Huong, NTL; Chau, NQ; Huong, LQ; Thao, LT; Hong, LTA; Oanh, TTM; Islam, J; Roberts, CM; Chalkidou, K, Combating antimicrobial resistance: quality standards for prescribing for respiratory infections in Vietnam, Lancet Global Health, 2016, 4 (11), pp. E789-E789
dcterms.dateAccepted2016-08-25
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/
dc.date.updated2020-02-14T01:30:29Z
dc.description.versionVersion of Record (VoR)
gro.rights.copyright© 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
gro.hasfulltextFull Text
gro.griffith.authorChalkidou, Kalipso


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record